Inflammation Research

, Volume 44, Issue 8, pp 313–316 | Cite as

Production of PAF-acether by synovial fluid neutrophils in rheumatoid arthritis

  • P. Hilliquin
  • A. Dulioust
  • C. Gregoir
  • A. Arnoux
  • C. J. Menkès
Original Research Papers


PAF-acether (PAF) is a pro-inflammatory phospholipid molecule potentially involved in the pathogenesis of arthritis. PAF and related metabolites have been isolated in the synovial fluid from patients with arthritis.

The aim of this study was to determine PAF production by neutrophils isolated from synovial fluid and blood in patients with rheumatoid arthritis. Blood neutrophils from normal donors were also studied for their capacity to form PAF. Neutrophils were stimulated with the calcium ionophore A23187 (2µM) for 1 to 60min. PAF released in the medium and PAF associated to cells were measured.

In synovial fluid neutrophils, PAF production began as soon as 1 min of stimulation (16.1 ± 6.3 pmol per 1 × 106 cells) and reached a maximum at 20min: 29.2 ± 2.8 pmol per 1 × 106 cells (mean ± SEM, n = 5). The amount of PAF released in the supernatant increased with the length of stimulation and was maximal after 30min (33.5%, percentage of released over total PAF, n = 5). After A23187 stimulation, similar amounts of PAF were produced by blood neutrophils from RA and control patients. However, neutrophils isolated from the joint had a lower capacity to produce PAF than blood neutrophils from the same patients.

The present results demonstrate the synthesis and release of PAF by synovial fluid neutrophils. They suggest that neutrophils may be the source of PAF locally present in the joint. Newly synthetised PAF could participate in the amplification of the local inflammatory reaction.

Key words

Platelet-activating factor Neutrophils Rheumatoid arthritis Synovial fluid 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Benveniste J. Aberrations in membrane structure and function. In: Karnovsky ML, Leaf A, Bolis LC, editors. Biological membranes. Progress Clin Biol Research. New York: Alan R. Liss Inc., 1988;282:73–85.Google Scholar
  2. [2]
    Pinckard RN, Ludwig JC, McManus LM. Platelet-activating factor. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation. New York: Raven Press, Ltd, 1988;139–67.Google Scholar
  3. [3]
    Roubin R, Tencé M, Mencia-Huerta JM, Arnoux B, Ninio E, Benveniste J. A chemically defined monokine: Macrophage-derived platelet-activating factor (PAF-acether). In: Pick E, editor. Lymphokines. New York: Academic Press, 1983;8:249–76.Google Scholar
  4. [4]
    Camussi G, Aglietta M, Malavasi F, et al. The release of platelet-activating factor from human endothelial cells in culture. J Immunol 1983;131:2397–403.Google Scholar
  5. [5]
    Lotner GZ, Lynch JM, Betz SJ, Henson PM. Human neutrophil-derived platelet-activating factor. J Immunol 1980;124:676–84.Google Scholar
  6. [6]
    Jouvin-Marche E, Ninio E, Beaurain G, Tencé M, Niaudet P, Benveniste J. Biosynthesis of PAF-acether. Precursors of PAF-acether and acetyl-transferase activity in human leukocytes. J Immunol 1984;133:892–8.Google Scholar
  7. [7]
    Wirthmueller URS, De Weck AL, Dahinden CA. Platelet-activating factor production in human neutrophils by sequential stimulation with granulocyte-macrophage colony-stimulating factor and the chemotactic factors C5A or formyl-methionylleucyl-phenylalanine. J Immunol 1989;142:3213–8.Google Scholar
  8. [8]
    Hilliquin P, Menkès CJ, Laoussadi S, Benveniste J, Arnoux B. Presence of PAF-acether in rheumatic diseases. Ann Rheum Dis 1992;51:29–31.Google Scholar
  9. [9]
    Arnett FC, Edworthy SM, Bloch DA, et al. American Rheumatism Association, 1987, revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.Google Scholar
  10. [10]
    Benveniste J, Henson PM, Cochrane CG. Leukocyte dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med 1972;136:1357–77.Google Scholar
  11. [11]
    Nunez D, Chignard M, Korth R, et al. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors Kadsurenone and CV 3988. Eur J Pharmacol 1986;123:197–205.Google Scholar
  12. [12]
    Chilton FH, Marshall Ellis J, Olson SC, Wykle RL. 1-0-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. J Biol Chem 1984;259:12014–9.Google Scholar
  13. [13]
    Dulioust A, Vivier E, Meslier N, Roubin R, Haye-Legrand I, Benveniste J. Biosynthesis of PAF-acether. PAF-acether but not leukotriene C4 production is impaired in cultured macrophages. Biochem J 1989;263:165–71.Google Scholar
  14. [14]
    Palmantier R, Dulioust A, Maiza H, Benveniste J, Ninio E. Biosynthesis of PAF-acether. XIV. PAF-acether output in murine peritoneal macrophages is regulated by the level of acetylhydrolase. Biochem Biophys Res Commun 1989;162:475–82.Google Scholar
  15. [15]
    Hirafuji M, Mencia-Huerta JM, Benveniste J. Regulation of PAF-acether (platelet-activating factor) biosynthesis in cultured human vascular endothelial cells stimulated with thrombin. Biochim Biophys Acta 1987;930:359–69.Google Scholar
  16. [16]
    Dulioust A, Hilliquin P, Benveniste J, Menkès CJ, Arnoux B. PAF-acether acetylhydrolase activity is increased in patients with rheumatic diseases. Scand J Rheumatol 1992;21:61–4.Google Scholar
  17. [17]
    Vercellotti GM, Yin HQ, Gustafson KS, Nelson RD, Jacob HS. Platelet-activating factor primes neutrophil responses to agonists: Role in promoting neutrophil-mediated endothelial damage. Blood 1988;71:1100–7.Google Scholar
  18. [18]
    Camussi G, Tetta C, Bussolino F, et al. Mediators of immunecomplex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation. Int Arch Allergy Appl Immunol 1981;64:25–41.Google Scholar

Copyright information

© Birkhäuser Verlag 1995

Authors and Affiliations

  • P. Hilliquin
    • 1
  • A. Dulioust
    • 1
  • C. Gregoir
    • 1
  • A. Arnoux
    • 2
  • C. J. Menkès
    • 1
  1. 1.Service de Rheumatologie AHôpital CochinParisFrance
  2. 2.INSERMClamartFrance

Personalised recommendations